AstraZeneca Statistics and Facts (2021) | By the Numbers



AstraZeneca Statistics and Facts

Here are a few of the most interesting AstraZeneca statistics and facts I was able to dig up. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

AstraZeneca Statistics and FactsPlease note that some of these numbers are easier to find than others. A few of these AstraZeneca stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%

AstraZeneca Facts

  • Website: www.astrazeneca.com
  • Year Founded: 1913 (Astra AB), 1993 (Zeneca Group plc), 1999 merger
  • Headquarters: Cambridge, England
  • CEO: Pascal Soriot
  • Key Products: Sybicort, Tagrisso, Nexium, Crestor, Farxiga, Brilinta, Pulmicort, Faslodex and Zoladex

AstraZeneca Statistics

AstraZeneca number of employees:

70,600 employees

Last updated 1/1/20


AstraZeneca largest therapeutic area (based on sales):

Cardiovascular & Metabolic Diseases (36%)


AstraZeneca largest geographical region (based on sales):

US (31%)


AstraZeneca Sales Statistics

AstraZeneca 2018 sales by geography:

  • Emerging Markets: 33%
  • US: 33%
  • Europe: 21%
  • China: 18%
  • Ex-China:15%
  • Established ROW: 15%
  • Japan: 10%
  • Canada: 2%

source


AstraZeneca annual revenue: